Last $7.16 USD
Change Today -0.29 / -3.89%
Volume 1.1M
OSUR On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas A. Michels

Chief Executive Officer, President and Director, OraSure Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 32 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Douglas A. Michels, also known as Doug, has been the Chief Executive Officer and President of Orasure Technologies Inc. since joining on June 23, 2004. Mr. Michels has more than twenty-three years of experience in the medical device, diagnostics and managed care industries, primarily with the Johnson & Johnson family of companies. He served as Group Vice President of Global Marketing of Ortho-Clinical Diagnostics Inc. He served as President of Ortho-Clinical Diagnostics ...

Read Full Background

Corporate Headquarters*

220 East First Street
Bethlehem, Pennsylvania 18015

United States

Phone: 610-882-1820
Fax: 610-882-1830

Board Members Memberships*

Chief Executive Officer, President and Director
Director, Member of Audit Committee and Member of Compensation Committee


BS 1978
University of Illinois-Urbana-Champaign
MBA 1990
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$563,408

Stock Options*

Restricted Stock Awards$440,003
All Other Compensation$4,000
Exercisable Options601,593
Exercisable Options Value$435,592
Unexercisable Options349,246
Unexercisable Options Value$2,346
Total Value of Options$437,938
Total Number of Options950,839

Total Compensation*

Total Annual Cash Compensation$1,036,878
Total Short Term Compensation$563,408
Other Long Term Compensation$444,003
Total Calculated Compensation$2,136,680
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $7.16 USD -0.29


Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
Ronan O’Caoimh Co-Founder, Chairman, Chief Executive Officer and Chairman of Compensation Committee
Trinity Biotech plc
John J. Sperzel III, B.Sc.Chief Executive Officer, President and Director
Chembio Diagnostics, Inc.
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at